Quick Answer
ZEVRA THERAPEUTICS, INC. reported Net Income of $83.23 million for fiscal year 2025.
ZEVRA THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $83.23M | +178.9% |
| 2024 | -$105.51M | -129.1% |
| 2023 | -$46.05M | -72.0% |
| 2022 | -$26.77M | -212.9% |
| 2021 | -$8.55M | +33.0% |
| 2020 | -$12.76M | +48.0% |
| 2019 | -$24.52M | +56.6% |
| 2018 | -$56.47M | -30.1% |
| 2017 | -$43.39M | -162.7% |
| 2016 | -$16.52M | +69.8% |
| 2015 | -$54.66M | -123.5% |
| 2014 | -$24.45M | -367.9% |
| 2013 | -$5.23M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$544.0K | +98.4% | -100.7% |
| June 30, 2025 | $74.71M | +474.9% | +2510.7% |
| March 31, 2025 | -$3.10M | +81.4% | +90.7% |
| September 30, 2024 | -$33.23M | -220.5% | -66.8% |
| June 30, 2024 | -$19.93M | -674.4% | -19.9% |
| March 31, 2024 | -$16.62M | -25.8% | -60.3% |
| September 30, 2023 | -$10.37M | -56.7% | -302.9% |
| June 30, 2023 | -$2.57M | +89.3% | +80.5% |
- ZEVRA THERAPEUTICS, INC. showed an increase of +178.9% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, ZEVRA THERAPEUTICS, INC.’s net income has grown by 1692.6% (from -$5.23 million to $83.23 million).
- The most recent figure is from ZEVRA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: